This document discusses treatment approaches for ovarian cancer. It notes that surgery followed by platinum-based chemotherapy is the standard first-line treatment. Recent trials show neoadjuvant chemotherapy followed by interval debulking surgery may be an alternative approach with less morbidity. Dose-dense chemotherapy regimens and the addition of targeted therapies like bevacizumab to chemotherapy are also discussed as approaches to improve outcomes. Ongoing trials are further exploring the benefits of intraperitoneal chemotherapy and optimal integration of targeted therapies.